Back to Search
Start Over
Ganciclovir and Its Hemocompatible More Lipophilic Derivative Can Enhance the Apoptotic Effects of Methotrexate by Inhibiting Breast Cancer Resistance Protein (BCRP)
- Source :
- International Journal of Molecular Sciences, Vol 22, Iss 7727, p 7727 (2021), International Journal of Molecular Sciences, Volume 22, Issue 14
- Publication Year :
- 2021
- Publisher :
- MDPI AG, 2021.
-
Abstract
- Efflux transporters, namely ATP-binding cassette (ABC), are one of the primary reasons for cancer chemoresistance and the clinical failure of chemotherapy. Ganciclovir (GCV) is an antiviral agent used in herpes simplex virus thymidine kinase (HSV-TK) gene therapy. In this therapy, HSV-TK gene is delivered together with GCV into cancer cells to activate the phosphorylation process of GCV to active GCV-triphosphate, a DNA polymerase inhibitor. However, GCV interacts with efflux transporters that are responsible for the resistance of HSV-TK/GCV therapy. In the present study, it was explored whether GCV and its more lipophilic derivative (1) could inhibit effluxing of another chemotherapeutic, methotrexate (MTX), out of the human breast cancer cells. Firstly, it was found that the combination of GCV and MTX was more hemocompatible than the corresponding combination with compound 1. Secondly, both GCV and compound 1 enhanced the cellular accumulation of MTX in MCF-7 cells, the MTX exposure being 13–21 times greater compared to the MTX uptake alone. Subsequently, this also reduced the number of viable cells (41–56%) and increased the number of late apoptotic cells (46–55%). Moreover, both GCV and compound 1 were found to interact with breast cancer resistant protein (BCRP) more effectively than multidrug-resistant proteins (MRPs) in these cells. Since the expression of BCRP was higher in MCF-7 cells than in MDA-MB-231 cells, and the cellular uptake of GCV and compound 1 was smaller but increased in the presence of BCRP-selective inhibitor (Fumitremorgin C) in MCF-7 cells, we concluded that the improved apoptotic effects of higher MTX exposure were raised mainly from the inhibition of BCRP-mediated efflux of MTX. However, the effects of GCV and its derivatives on MTX metabolism and the quantitative expression of MTX metabolizing enzymes in various cancer cells need to be studied more thoroughly in the future.
- Subjects :
- 0301 basic medicine
Abcg2
viruses
Genetic enhancement
Apoptosis
Pharmacology
0302 clinical medicine
ATP Binding Cassette Transporter, Subfamily G, Member 2
Biology (General)
skin and connective tissue diseases
Spectroscopy
biology
methotrexate (MTX)
Chemistry
General Medicine
Neoplasm Proteins
Computer Science Applications
030220 oncology & carcinogenesis
MCF-7 Cells
Female
Efflux
Multidrug Resistance-Associated Proteins
ganciclovir (GCV)
MCF-7/MDA-MB-231 human breast cancer cells
medicine.drug
Ganciclovir
QH301-705.5
Breast Neoplasms
Antiviral Agents
Article
Catalysis
Inorganic Chemistry
03 medical and health sciences
Cell Line, Tumor
Human Umbilical Vein Endothelial Cells
medicine
Humans
Physical and Theoretical Chemistry
QD1-999
Molecular Biology
Organic Chemistry
Cancer
medicine.disease
Methotrexate
030104 developmental biology
Thymidine kinase
Cancer cell
biology.protein
breast cancer resistant protein (BCRP)
multidrug resistance (MDR)
Subjects
Details
- ISSN :
- 14220067
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- International Journal of Molecular Sciences
- Accession number :
- edsair.doi.dedup.....9c16c3aa0ca568a2e65488e30b5b700b
- Full Text :
- https://doi.org/10.3390/ijms22147727